-
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia and Sickle Cell Disease in Italy
19 Sep 2025 05:49 GMT
… Europe -
LONDON--(BUSINESS WIRE)--Vertex Pharmaceuticals (Nasdaq: VRTX) announced today … ema.europa.eu.
About Vertex
Vertex is a global biotechnology company … available.
(VRTX-GEN)
Contacts
Vertex Pharmaceuticals Incorporated
Investors:
InvestorInfo@vrtx.com …
-
1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals
15 Sep 2025 12:56 GMT
… .
There are 28 analysts following Vertex Pharmaceuticals. None have issued sell ratings … stock a Wall Street darling.
Vertex Pharmaceuticals is the only company marketing … down permanently. Thanks largely to Vertex Pharmaceuticals, a majority of folks born …
-
US open: Major indices trade higher after Fed rate cut, Nasdaq leads early gains
19 Sep 2025 02:36 GMT
… . (ALGN) $129.44 -1.86%
Vertex Pharmaceuticals Inc. (VRTX) $387.15 -1 …
-
A Reaffirmation to Our Call for Reform: Response to Rebuttal Letter Regarding “A Call for Reckoning and Reform in Interventional Pain Medicine and Neuromodulation Research” [Response to Letter]
18 Sep 2025 22:44 GMT
… an accurate representation of the pharmacokinetic profiles of opioids included in … ; and Speaker Bureau involvement for Vertex Pharmaceuticals, outside the submitted work. Dr … senior medical advisor for Apurano Pharma, outside the submitted work. The …
-
Gene-Edited Cells Alleviate Pain Crisis in SCD
18 Sep 2025 14:12 GMT
… myeloablative conditioning with pharmacokinetically adjusted busulfan before exa … study was designed by Vertex Pharmaceuticals Incorporated, in collaboration … Sangamo Therapeutics, Spotlight Therapeutics, Vertex Pharmaceuticals, and Vindico Medical Education …
-
The Escalator: Flagship Pioneering, Takeda, GCI Health and more
18 Sep 2025 13:31 GMT
… The National Association of Specialty Pharmacy welcomed four new board members … as scientific advisor.
Imbria Pharmaceuticals named Pavan Cheruvu, MD … .
Three scientists — Vertex Pharmaceuticals’ Paul Negulescu, former Vertex researcher Jesús González and …
-
This 12% Dividend Is on Sale as a $30 Bn ’Hidden’ Move Sparks Buying Opportunity
18 Sep 2025 09:58 GMT
… purple) have beaten the benchmark pharma ETF (in blue), even … threat of tariffs on imported pharmaceuticals and pressure from the … if the dour mood around pharma brightens—even a bit. … include well-known firms like Vertex Pharmaceuticals (NASDAQ:VRTX) and Eli …
-
Interleukin-13 Inhibitors Market Predicted to Surge During the Forecast Period (2025-2034) Due to Breakthrough Therapies in Atopic Dermatitis, Asthma, CRSwNP, and Others | DelveInsight
17 Sep 2025 22:54 GMT
… Lilly and Company, LEO Pharma, ASLAN Pharmaceuticals, UCB Pharma, and others.
ASLAN Pharmaceuticals'; Eblasakimab is an … Squibb, Eli Lilly and Company, Vertex Pharmaceuticals Incorporated, Amgen Inc., AbbVie Inc., …
-
US close: Stocks mixed as Fed rate cut sparks volatile swings
17 Sep 2025 22:10 GMT
… . (ALGN) $129.44 -1.86%
Vertex Pharmaceuticals Inc. (VRTX) $387.15 -1 …
-
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution
17 Sep 2025 18:42 GMT
… t been easy. Vertex Pharmaceuticals received FDA approval for … effects.
Munich-based pharmaceutical company Vertanical is perhaps … medical doctor and serial pharmaceutical and supplement entrepreneur, … the country and its pharma industry: childhood vaccinations, …
About
© 1995-2025